SoFi Technologies (SOFI) is set to release its first-quarter 2025 earnings next week, and many investors are watching closely ...

Der US-Aktienmarkt hat seine besten Zeiten nach Ansicht von Jefferies längst hinter sich, weshalb Anleger sich auf weitere ...

The US stock market is well past its best days and investors should be prepared to see further declines in the nation’s ...

Abu Dhabi Investment Authority has acquired a stake worth ~$5M in Jefferies Financial Group (NYSE:JEF) unit Jefferies Credit ...

As gold prices keep hitting record highs, Jefferies analysts said shares of companies that mine the precious metal could ...

Fox is heading into the snakepit for its latest reality order. The network has handed a greenlight to The Snake, a social ...

Jefferies reiterated a Buy rating on Lowe's Companies (NYSE:LOW) after meeting with management last week. Analyst Jonathan ...

Fox has picked up the competition series “The Snake,” with comedian Jim Jefferies onboard to host. The series will air on Fox ...

Power and utilities companies are facing a tough challenge in making clean, renewable energy more affordable and abundant.

Jefferies' Christopher Wood predicts a decline in US stocks, Treasury bonds, and the dollar, suggesting the US market has ...

US stocks have been shunned by investors looking to flee from tariff-related turmoil that has cast a dark cloud over the country’s international reputation, but Jefferies believes American ...

Jefferies analyst Kelly Shi raised the firm’s price target on Summit Therapeutics (SMMT) to $44 from $31 and keeps a Buy rating on the shares.